LIEBERMAN GERALD M has filed 19 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 33505 shares of Entera Bio Ltd. ($ENTX) on January 01, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 38294 | $0.00 | 363,254.0000 | 47,089,814 | 11.78% | 0.08% |
| June 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | LIEBERMAN GERALD M | Not found | A | Restricted Share Units | 14492 | $0.00 | 14,492.0000 | 1,159,000,000 | 9999.99% | 0.00% |
| June 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | LIEBERMAN GERALD M | Not found | M | Ordinary Shares | 9632 | $0.00 | 115,657.0000 | 1,159,000,000 | 9.08% | 0.00% |
| June 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | LIEBERMAN GERALD M | Not found | M | Restricted Share Units | 9632 | $0.00 | 0.0000 | 1,159,000,000 | 100.00% | 0.00% |
| April 1, 2025 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | M | Ordinary Shares, par value NIS 0.0000769 per share | 23952 | $1.00 | 324,960.0000 | 37,650,179 | 7.96% | 0.06% |
| April 1, 2025 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | M | Warrant (right to buy) | 23952 | $0.00 | 28,509.0000 | 37,650,179 | 45.66% | 0.06% |
| Jan. 15, 2025 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 10717 | $0.00 | 301,008.0000 | 37,650,179 | 3.69% | 0.03% |
| Jan. 15, 2025 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Oct. 2, 2024 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 11269 | $0.00 | 290,291.0000 | 37,644,612 | 4.04% | 0.03% |
| Aug. 27, 2024 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 27261 | $0.00 | 279,022.0000 | 29,007,794 | 10.83% | 0.09% |
| June 15, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | LIEBERMAN GERALD M | Not found | M | Ordinary Shares | 21108 | $0.00 | 106,025.0000 | 1,123,000,000 | 24.86% | 0.00% |
| June 15, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | LIEBERMAN GERALD M | Not found | M | Restricted Share Units | 21108 | $0.00 | 0.0000 | 1,123,000,000 | 100.00% | 0.00% |
| June 6, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | LIEBERMAN GERALD M | Not found | A | Restricted Share Units | 9632 | $0.00 | 9,632.0000 | 1,123,000,000 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Dec. 22, 2023 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | P | Warrants (right to buy) | 23952 | $0.13 | 23,952.0000 | 0 | 9999.99% | 0.00% |
| Dec. 22, 2023 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 23952 | $0.71 | 251,761.0000 | 0 | 10.51% | 0.00% |
| Aug. 21, 2023 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 20000 | $0.59 | 239,009.0000 | 0 | 9.13% | 0.00% |
| Jan. 2, 2023 | Entera Bio Ltd. | $ENTX | LIEBERMAN GERALD M | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |